Stockscreener 앱 받기
192.57
0.14%
-0.1035
전일 마감가:
$192.67
열려 있는:
$190.61
하루 거래량:
84,865
Relative Volume:
0.09
시가총액:
$21.31B
수익:
$11.28B
순이익/손실:
$1.07B
주가수익비율:
21.24
EPS:
9.0657
순현금흐름:
$1.33B
1주 성능:
-2.15%
1개월 성능:
-2.84%
6개월 성능:
+8.07%
1년 성능:
+8.12%
1일 변동 폭
$190.41
$193.39
1주일 범위
$187.50
$198.78
52주 변동 폭
$164.65
$213.50
퀘스트 다이아그노스틱스 Stock (DGX) Company Profile
명칭
Quest Diagnostics Inc
전화
(973) 520-2700
주소
500 PLAZA DRIVE, SECAUCUS
Compare DGX vs TMO, DHR, IDXX, A, WAT
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DGX
Quest Diagnostics Inc
|
192.47 | 21.33B | 11.28B | 1.07B | 1.33B | 9.0657 |
TMO
Thermo Fisher Scientific Inc
|
467.93 | 174.37B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
174.51 | 123.97B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.49 | 45.07B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
113.47 | 32.36B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.29 | 30.15B | 3.17B | 642.63M | 516.49M | 10.77 |
퀘스트 다이아그노스틱스 Stock (DGX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-04-02 | 개시 | Redburn Atlantic | Buy |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-01-06 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-12-17 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 재개 | Jefferies | Buy |
| 2024-10-23 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-08-28 | 재개 | Evercore ISI | In-line |
| 2024-07-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2023-12-12 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-29 | 개시 | Piper Sandler | Neutral |
| 2023-05-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-04-03 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-01-23 | 개시 | Evercore ISI | In-line |
| 2022-11-17 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-04-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-02-23 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-02 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-01-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-04 | 업그레이드 | UBS | Neutral → Buy |
| 2021-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-10-21 | 업그레이드 | Argus | Hold → Buy |
| 2020-07-29 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-07-14 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-06-09 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2020-06-02 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2020-04-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-27 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-04-27 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2020-03-27 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-08 | 개시 | Wells Fargo | Underweight |
| 2020-01-07 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-07-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-04-02 | 업그레이드 | Jefferies | Hold → Buy |
| 2019-03-18 | 재개 | Credit Suisse | Neutral |
| 2019-01-31 | 다운그레이드 | Argus | Buy → Hold |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-03 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2018-11-30 | 다운그레이드 | Goldman | Buy → Neutral |
모두보기
퀘스트 다이아그노스틱스 주식(DGX)의 최신 뉴스
Quest Diagnostics Incorporated $DGX Shares Sold by Keybank National Association OH - MarketBeat
DGX SEC FilingsQuest Diagnostics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Quest Diagnostics Incorporated $DGX Shares Acquired by Davis Selected Advisers - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Increased by Artemis Investment Management LLP - MarketBeat
Quest Diagnostics Incorporated (NYSE:DGX) Short Interest Update - MarketBeat
[8-K] QUEST DIAGNOSTICS INC Reports Material Event - Stock Titan
Quest Diagnostics Incorporated $DGX Shares Sold by Pictet Asset Management Holding SA - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Sold by Danica Pension Livsforsikringsaktieselskab - MarketBeat
Quest Diagnostics Inc. stock outperforms competitors on strong trading day - MarketWatch
Vanguard reports 8.27M Quest Diagnostics shares (NYSE: DGX) stake - Stock Titan
Quest Diagnostics Inc (DGX) Stock Price & 30 Year Financial Data - GuruFocus
Quest Diagnostics Incorporated $DGX Shares Purchased by UBS Group AG - MarketBeat
Quest Diagnostics Incorporated $DGX Shares Purchased by Vanguard Group Inc. - MarketBeat
Valmont Industries posts upbeat Q1 results, joins UnitedHealth Group, Quest Diagnostics and other big stocks moving higher on Tuesday - MSN
Quest Diagnostics Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Vanguard reports 6.10M-share stake in Quest Diagnostics (DGX) — 5.54% - Stock Titan
Quest Diagnostics (DGX) sells $500M 5.00% senior notes due 2036 at 98.751% - Stock Titan
Quest Diagnostics Debt Raise And ctDNA Alliance Spark Valuation Questions - Yahoo Finance
JPMorgan Mid Cap Value Fund's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
BlackRock Systematic Multi-Strategy Fund's Quest Diagnostics Inc(DGX) Holding History - GuruFocus
Quest Diagnostics Prices $500 Million of Senior Notes - GuruFocus
Smart Money is Buying Quest Diagnostics Inc. (DGX) - The Acquirer's Multiple
Quest Diagnostics Inc (DGX) Stock Price, Trades & News - GuruFocus
Quest Diagnostics Incorporated (DGX) stock price, news, quote and history - Yahoo Finance Australia
Quest Diagnostics prices $500 million senior notes offering By Investing.com - Investing.com Canada
Quest Diagnostics Inc files for senior notes, size not disclosed - marketscreener.com
Quest Diagnostics (DGX) launches senior note offering; may repay $500M 2026 notes - Stock Titan
Advisors Capital Management LLC Buys 16,194 Shares of Quest Diagnostics Incorporated $DGX - MarketBeat
Evercore ISI Group Maintains Quest Diagnostics (DGX) In-Line Recommendation - MSN
Quest Diagnostics Incorporated $DGX Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
[Form 4] QUEST DIAGNOSTICS INC Insider Trading Activity - Stock Titan
Quest Diagnostics (DGX) SVP reports 49-share dividend reinvestment - Stock Titan
Quest Diagnostics (NYSE: DGX) director acquires shares through dividend reinvestment - Stock Titan
Dividend plan boosts Quest Diagnostics (NYSE: DGX) director stake - Stock Titan
Quest Diagnostics (DGX) director boosts holdings with small dividend reinvestment - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP reports small 39-share acquisition - Stock Titan
Quest Diagnostics (NYSE: DGX) SVP adds 37 shares through dividend reinvestment - Stock Titan
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
Quest Diagnostics: Good Q1, Solid Business, Steady Share Price Upside Likely (NYSE:DGX) - Seeking Alpha
Copeland Capital Management LLC Cuts Stake in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics Incorporated $DGX Stock Holdings Decreased by Cwm LLC - MarketBeat
These Companies Are Raising Guidance This Earnings Season - TradingView
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG), Quest Diagnostics (DGX) and Merck & Company (MRK) - The Globe and Mail
Zurcher Kantonalbank Zurich Cantonalbank Has $14.02 Million Position in Quest Diagnostics Incorporated $DGX - MarketBeat
Quest Diagnostics (NYSE: DGX) boosts Q1 2026 earnings on 11% volume growth - Stock Titan
Quest Diagnostics deal helps push Secaucus office tower past 75% occupancy - Yahoo Finance
Quest Diagnostics Stock Gains 5% After Q1 Earnings Exceed Analyst Expectations - TIKR.com
Quest Diagnostics (NYSE:DGX) Price Target Raised to $229.00 - MarketBeat
Quest Diagnostics (NYSE:DGX) Stock Price Expected to Rise, Barclays Analyst Says - MarketBeat
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Earnings - Benzinga
퀘스트 다이아그노스틱스 (DGX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.82%
0.11%
자본화:
|
볼륨(24시간):